SCHEMBL2553141

SCHEMBL2553141

Cc1nc(S(C)(=O)=O)cnc1OC1CCC(OC2CCN(C(C)C(F)(F)F)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2551327 0.88 GPR119 (0.49) GPR119
SCHEMBL2550758 0.84 GPR119 (0.65) GPR119
SCHEMBL2575142 0.84 GPR119 (0.65) GPR119
SCHEMBL2553115 0.83 GPR119 (0.69) GPR119
SCHEMBL2553254 0.83 GPR119 (0.69) GPR119
SCHEMBL2553816 0.83 GPR119 (0.74) GPR119
SCHEMBL2553814 0.83 GPR119 (0.74) GPR119
SCHEMBL14634598 0.83 GPR119 (0.74) GPR119
SCHEMBL12283356 0.83 GPR119 (0.74) GPR119
SCHEMBL14634282 0.82 GPR119 (0.47) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556056-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2013-02-13 EP disclosed
WO-2011127051-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2011-10-13 WO disclosed